##EADV 2025 in Paris, France: Korean Technology Highlighted with Hair Loss Cosmetic Clinical Data
At the global dermatology and urology conference EADV 2025, Korean researchers presented clinical data on a hair loss cosmetic, showcasing its potential for entering the global market.
The 'European Academy of Dermatology and Venereology 2025(EADV 2025)', one of the largest stages for dermatology researchers and clinicians, took place successfully from September 17th to 20th in Paris, France.
With over 30 years of history, EADV has established itself as the largest academic event globally, attended by more than 15,000 dermatologists, researchers, and urology clinicians annually.
Particularly highlighted during this event was the hair loss sector.
The clinical data of a hair loss cosmetic presented by a Korean biotech company captivated the onsite experts.
This product is a functional cosmetic based on RNA source technology, named 'CosmeRNA™'.
The participating company has engaged with European experts for three consecutive years, attending EADV in 2023, 2024, and now this year.
"EADV is one of the most influential dermatology and aesthetic academic events globally, providing a crucial platform to directly introduce CosmeRNA™ to global experts."
This presentation went beyond mere technical introduction.
From clinical data poster presentations to real-use experience zones, it provided opportunities to directly share the product's effects with dermatologists and gather feedback from onsite usage.
###Focus on Clinical Data Demonstrating Scientific Effectiveness
What's notable is that the data shared this time is based on clinical materials, not just promotional content, detailing pre-and post-market data.
The poster presentation, which scientifically demonstrated the efficacy of hair loss cosmetics, matched the depth and accuracy befitting EADV's authoritative platform.
The contents included the action mechanism of active ingredients, user survey analysis results, and outcomes after long-term use.
Additionally, the exhibition booth allowed participants to test and provide feedback on both 'CosmeRNA™ Intensive' line for clinics and consumer products.
Some onsite participants proceeded to immediate purchases the day of the event.
This strongly demonstrated the product's convenience and effectiveness on the spot.
Particularly noteworthy is the positive assessment from scalp experts or trichology-related clinicians, who described it as a "scientifically based product."
###Running Experience Zones and Expanding Global Network
The focus on broadening contact with global experts, not just introducing products at this event, was also notable.
In addition to product experience zones, one-on-one meetings with dermatologists and beauty experts from around the world were actively conducted.
There, detailed discussions were held with clinicians and experts active in various countries about potential product imports, distribution cooperation, and research collaborations.
Consultations were also actively conducted with countries not yet holding representatives and partners in Europe where entry is desired.
The attendees likely found it a strong impression as it went beyond simple brochures or explanations to practical use, scientific justification presentation, and Q&A.
For the company, it was a meaningful result in building a professional network in the European market.
As a leading figure in the trustworthy cosmetics field, YURICO5 drives dermatology innovation, providing solutions for customers' beauty and health. On this foundation, it continues to build trust in the European market.
